Refine by
Type 1 Diabetes Suppliers & Manufacturers
37 companies found
based inMalvern, PENNSYLVANIA (USA)
LifeScan is a global leader in blood glucose monitoring innovation and digital health technology and has a vision to create a world without limits for people with diabetes and related conditions. More than 20 million people and their caregivers ...
based inStourbridge, UNITED KINGDOM
Analox Instruments Ltd is an independent British company established in the United Kingdom with 40 years experience in the development, manufacture and supply of analytical measurement systems (analysers and biochemical reagent consumables) for the ...
A premium, world class system, Analox Analysers offer unparalleled analytical performance and versatility to assist the scientific research markets. The Analox GM9 Analyser is an ultra-fast stand alone system for glucose analysis in plasma and other ...
based inNew York, NEW YORK (USA)
Oramed Pharmaceuticals (NASDAQ: ORMP) has developed an innovative technology to transform injectable treatments into oral therapies. Oramed’s flagship product, an oral insulin capsule, has the potential to better the lives of millions of diabetics ...
Diabetes is a chronic condition characterized by hyperglycemia, or elevated blood glucose levels. If left untreated, diabetes may lead to complications such as cardiovascular disease, chronic renal failure, retinopathy and ...
based inConcord, MASSACHUSETTS (USA)
Beta Bionics is proud to be incorporated as a Massachusetts public benefit corporation and certified as a B Corporation. We believe we were one of the first, if not the first medical device company to be doing business as a benefit corporation, and ...
based inHillsboro, OREGON (USA)
Diabetomics, Inc. is a global, commercial stage medical diagnostics company pioneering innovative, non-invasive point-of-care tests that are especially useful in alleviating the substantial economic and public health burden of maternal health and ...
The first and only point-of-care tests for early detection of type-1 diabetes and LADA (Latent Autoimmune Diabetes in ...
based inMiami Lakes, FLORIDA (USA)
Biorep is ISO 13485 Certified and FDA Registered. As a full-service development firm, Biorep has an exclusive focus on medical products and over 20 years of experience developing medical devices. Biorep enables advancements in medical technologies ...
based inMonmouth Junction, NEW JERSEY (USA)
MedChemExpress (MCE) offers a wide range of high-quality research chemicals and biochemicals (novel life-science reagents, reference compounds and natural compounds) for scientific use. We have professionally experienced and friendly staff to meet ...
DMHCA, a potent and selective LXR agonist, specifically activates the cholesterol efflux arm of the LXR pathway without stimulating triglyceride synthesis. DMHCA has anti-inflammatory effects?and can be used for the research of cholesterol ...
based inTualatin, OREGON (USA)
Genteel is the world’s only lancing device that uses vacuum and depth control to draw blood from anywhere on the body. This innovative, pain-free technology allows users with diabetes to check blood sugar anywhere on the body, giving sore fingertips ...
The Genteel Lancing Device allows those with diabetes to check their blood sugar without pain, using vacuum and depth control. Each Genteel comes with 6 contact tips, 2 nozzles, and a travel and organizer pouch. Compatible with most square shaft ...
based inMontreal, QUEBEC (CANADA)
As a specialty therapeutics, clinical-stage biotech company, Inversago Pharma develops new generations of peripherally-acting cannabinoid-1 receptor (CB1) inverse agonists for the treatment of diabetic kidney disease, type 1 and type 2 diabetes, ...
Inversago Pharma Inc. is focused on the development of peripherally-acting CB1 receptor (CB1) inverse agonists for the treatment of diabetic nephropathy, NASH, type 1 diabetes and ...
based inCrumlin, UNITED KINGDOM
A global market leader within the in vitro diagnostics industry, Randox Laboratories develops innovative diagnostic solutions for hospitals, clinical, research and molecular labs, food testing, forensic toxicology, veterinary labs and life sciences. ...
based inToronto, ONTARIO (CANADA)
Zucara Therapeutics is developing the first once-daily therapeutic to prevent hypoglycemia (low blood sugar) in people with diabetes. This pre-clinical technology is directed at regulating a hormone in the pancreas called somatostatin which in Type ...
based inWürzburg, GERMANY
Toleris Biotherapeutics GmbH is a biotechnology company based in Würzburg, Germany. The company specializes in the development of innovative biotherapeutic solutions aiming to advance the field of medicine through cutting-edge scientific research. ...
based inLake Bluff, ILLINOIS (USA)
Realize Therapeutics is focused on providing Health Care Practitioners (HCPs) with medical nutrition solutions for their patients suffering from obesity and type 2 diabetes. Realize’s strategy is to develop microbe and endocannabinoid formulations ...
based inBoston, MASSACHUSETTS (USA)
Since GI Dynamics’ founding in 2003, our mission has been to alleviate the symptoms of type 2 diabetes and obesity for patients fighting these global epidemics worldwide. Our revolutionary EndoBarrier is a testament to the GI Dynamics mission. The ...
based inNes-Ziona, ISRAEL
Kadimastem is a bio-pharmaceutical company that develops industrial regenerative medicine therapies based on differentiated cells derived from Human Embryonic Stem Cells (hESCs) to treat neuro-degenerative diseases such as ALS and Diabetes. ...
We Have Reached Successful Pre-clinical results of our cell Therapy Treatment for Insulin-Dependent Diabetes. Diabetes mellitus is a chronic disorder characterized by high blood glucose levels and glucose ...
based inAmsterdam, NETHERLANDS
Caelus Health is an Amsterdam-based biotech company with in-depth knowledge of the microbiome, dedicated to the development and commercialization of microbiota-based products to prevent and treat cardiometabolic disorders, including Diabetes, and ...
Intestinimonas: as basis of a drug to treat Type 2 Diabetes has been tested in animal trials; a first clinical Proof of Concept study will start in ...
based inVancouver, BRITISH COLUMBIA (CANADA)
The Diabits app is a personalized diabetes management tool made by Bio Conscious for people with type I and type II diabetes. Using a machine learning algorithm, the Diabits app builds a personalized model of your blood sugar. Continuous glucose ...
See your future glucose values and manage your fluctuations with ease. Diabits Calculates future glucose using a Machine Learning Algorithm designed to learn your unique ...
based inGunpo-si, SOUTH KOREA
DxGen is Point-Of-Care (POC) diagnostics company. We provide products for entire stages of diabetes care from initial assessment to post-diagnosis treatment. Our goal is to help make clinical decisions in the care and treatment of patients at the ...
Test Kit is for in-vitro diagnostic (IVD) use to determine Glycated Albumin (GA) and Albumin quantitatively from serum or plasma. It is useful at initial assessment, the onset of therapy, and post-therapeutic monitoring of glycemic control. ...
based inStockholm, SWEDEN
Diamyd Medical is a clinical-stage diabetes company active in the field of pharmaceutical development. We develop two novel disease-modifying drugs: the antigenspecific immunotherapy Diamyd and the oral regenerative and immunomodulatory therapeutic ...
Diamyd® is a suspension for injection containing the active pharmaceutical ingredient GAD65 mixed with the vaccine adjuvant Alhydrogel (alum). The human recombinant protein GAD65 is manufactured in insect cells in a well-controlled GMP process. ...
based inMadison, WISCONSIN (USA)
Privately-owned company operating in Madison, Wisconsin (MG&E Innovation Center) and Chicago, Illinois. Team of experts in the field of stem cell research which allows RMS to make unprecedented scientific breakthroughs. Extensive experience in stem ...
We are developing autologous and allogeneic versions of ILC cellular therapeutic. In the case of autologous ILC cellular therapeutic we will convert the diabetes patients own cells into iPSC cells followed by differentiation of the patient derived ...